300261ABAChemSZSE

ABA Chemicals Corporation

雅本化学

300261

Shenzhen Stock Exchange

BoardChiNext of Shenzhen Stock Exchange
IndustryRaw Chemical Materials and Chemical Products Manufacturing
ISINCNE1000016S8
ListedSeptember 6, 2011
Websitewww.abachem.com
IR Emailinfo@abachem.com
Phone0512-53641368
Sourcecninfo.com.cn
AddressNo. 18, Dongfang East Road, Petrochemical Zone, Port Development Zone, Taicang Port, Taicang, Jiangsu

Company Overview

ABA Chemicals Corporation, also known as 雅本化学, is a manufacturing company listed on the ChiNext board of the Shenzhen Stock Exchange since 2011. The company specializes in the production of raw chemical materials and chemical products, with a focus on the pesticide industry. ABA Chemicals is actively engaged in developing innovative solutions and has established itself as a key player in the chemical manufacturing sector. The company operates primarily in the pharmaceutical and agricultural CDMO (Contract Development and Manufacturing Organization) sectors, implementing a "2+X" strategy that emphasizes innovation and collaboration with leading global enterprises. ABA Chemicals has developed a diverse product matrix that includes pesticide intermediates and derivative products, while also investing in synthetic biology, flow chemistry, and green carbon reduction initiatives. By leveraging a full-chain closed-loop synergy across R&D innovation, intelligent manufacturing, and green carbon reduction, ABA Chemicals aims to enhance its competitiveness and ensure sustainable growth in both the short and long term.

AI-generated from company disclosures and CNInfo data.

Company Profile

ABA is actively promoting its future-oriented "2+X" strategy, with innovative pharmaceutical and agricultural CDMO (Contract Development and Manufacturing Organization) businesses as the core. It firmly implements the "Key Customer Strategy," establishing sustained and stable strategic cooperative relationships with leading global pharmaceutical and agrochemical enterprises. The company has made in-depth deployments in innovative pharmaceutical and pesticide intermediates as well as derivative products, forming a gradient product matrix, and is steadily advancing the industrialization process. Meanwhile, the forward-looking layout and capability building in synthetic biology, flow chemistry, and green carbon reduction inject sustained momentum into the long-term development of its core businesses. Through the full-chain closed-loop synergy of the three core systems—"R&D Innovation, Intelligent Manufacturing, and Green Carbon Reduction"—the company has built core competitiveness that emphasizes both short-term growth and long-term resilience. Furthermore, ABA takes intelligentization as a key driver for future development and adheres to the tenet of "supplementing, extending, and strengthening the industrial chain" to build a full-life-cycle "R&D-Production" industrial chain that meets the needs of high-end and innovative products.

82 announcements tracked· Last: August 11, 2026

Key Financials

As of 2026-08-15T00:00:00.000+00:00
Revenue¥303.6M
Net Profit-¥57.6M
ROE-3.16%
Debt Ratio52.51%
Monetary Funds¥516.2M
Receivables¥388.9M
Goodwill¥214.4M
Total Shares963.3M

Announcements

82 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.